IDEXX Laboratories’ (NASDAQ:IDXX) EVP Michael Erickson sold 5,371 shares of company stock for over $3.36 million, reducing his ownership by nearly 30%. This sale follows the company reporting slightly missed EPS but increased revenue, and providing full-year 2026 guidance. IDEXX currently holds a “Moderate Buy” analyst consensus with a target price of $783.33.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
IDEXX Laboratories (NASDAQ:IDXX) EVP Sells $3,369,657.98 in Stock
IDEXX Laboratories’ (NASDAQ:IDXX) EVP Michael Erickson sold 5,371 shares of company stock for over $3.36 million, reducing his ownership by nearly 30%. This sale follows the company reporting slightly missed EPS but increased revenue, and providing full-year 2026 guidance. IDEXX currently holds a “Moderate Buy” analyst consensus with a target price of $783.33.